Survival Outcome After Percutaneous Hepatic Perfusion with High-Dose Melphalan for Liver-Dominant Metastatic Uveal Melanoma: A 10-Year Single-Center Experience. - Reiner, Carolin M.; Schneider, Martin A.; Weilert, Hauke; Welcker, Klara; Hoedtke, Jochen; Mahnken, Andreas H.; Stang, Axel; Brüning, Roland (Cancers, 2025)